Business

Commercial and scientific update

Commercial and scientific update.

articleOptibiotix Health PlcJuly 20, 20223/company/optibiotix-health-plc/news/commercial-and-scientific-update
Commercial and scientific update

About this update from Optibiotix Health Plc

[{"type":"text","content":"\n \n \n \n OptiBiotix Health plc\n \n \n \n \n (\n \n \n \"OptiBiotix\" or the \"Company\")\n \n \n \n \n  \n \n \n \n \n Commercial and scientific update\n \n \n \n \n  \n \n \n \n OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skincare, provides an update on recent scientific and commercial activities\n .\n \n \n \n  \n \n \n \n 1.  Launch of WellBiome at IFT, USA: The Company has developed a new formulation of WellBiome® as part of its health and wellness portfolio to support healthy ageing. The product has several European and USA health claims allowing on pack claims for heart health, bone health, cognitive health and metabolic health. The formulation is protected by a portfolio of trademarks and patents and was soft launched at IFT in Chicago, USA. The launch of WellBiome® is part of a strategy of extending the Company's product portfolio into other areas of healthcare.\n \n \n  \n \n \n 2.  Clinical Study with University of Hull: The Company is conducting a human intervention study with The University of Hull investigating the impact of WellBiome®\n on reducing post operative complications and hospital stay. The study is funded by the University of Hull with an intended start date either in Q4 2022 or Q1 2023, subject to NHS ethics approval. There is growing interest in the potential of prebiotics in post operative care as a means of reducing pain, surgical complications, and the length of hospital stay\n .  Whilst exploratory, if successful, this study could open up opportunities for WellBiome® in healthcare.\n \n \n  \n \n 3.  LeanBiome® Certified as anInformed Ingredient for Sports: The Company is pleased to announce that it has received approval for LeanBiome® as an Informed Ingredient (see  https://ingredient.wetestyoutrust.com/ingredient-search/optibiotix/leanbiome). This is an industry certification which demonstrates that LeanBiome® has been through rigorous independent testing by an authorised body to confirm that it is free from substances that are banned in sport. The risk of contamination with low levels of substances prohibited by the World Anti-Doping Agency (WADA) is a serious issue in sport. Certification of LeanBiome® as an informed ingredient is an important step in attra...

More updates from Optibiotix Health Plc